Atlas Trials

Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes

Clinical trial NCT04449692 · COMPLETED

Trial details

NCT number
NCT04449692
Sponsor
Steno Diabetes Center Copenhagen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 DiabetesHypoglycemia
Start date
2020-07-02
Primary completion
2021-01-04
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.